Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O'Brien Project Federico Guillermo Villamil; Nancy Elena Massenzio; Patricia Cristina Baré; Paula Andrea Cocco; Fernando Mario Cairo; Gastón Rafael Picchio;

Aging impairs fibrosis-4 index after sustained virologic response by direct-acting antivirals in chronic hepatitis C infection Tomoaki Nakajima; Yoshiyasu Karino; Shuhei Hige; Hirokazu Suii; Ryoji Tatsumi; Masakatsu Yamaguchi; Tomohiro Arakawa; Yasuaki Kuwata; Joji Toyota;